Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a

Cover Page

Cite item

Abstract

Anthrax is a particularly dangerous infectious disease that affects humans and livestock. It is characterized by intoxication, serosanguineous skin lesions, development of lymph nodes and internal organs, and may manifest itsself in either a cutaneous or septic form. The pathogenic agent is Bacillus anthracis, a grampositive, endospore-forming, rod-shaped aerobic bacterium. Efficacious vaccines that can rapidly induce a long-term immune response are required to prevent anthrax infection in humans. In this study, we designed three recombinant human adenovirus serotype-5-based vectors containing various modifications of the fourth domain of the B. anthracis protective antigen (PA). Three PA modifications were constructed: a secretable form (Ad-sPA), a non-secretable form (Ad-cPA), and a form with the protective antigen fused to the Fc fragment of immunoglobulin G2a (Ad-PA-Fc). All these forms exhibited protective properties against Bacillus anthracis. The highest level of protection was induced by the Ad-PA-Fc recombinant adenovirus. Our findings indicate that the introduction of the Fc antibody fragment into the protective antigen significantly improves the protective properties of the Ad-PA-Fc adenovirus against B. anthracis.

About the authors

D. N. Shcherbinin

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Author for correspondence.
Email: dim284@inbox.ru
Россия

I. B. Esmagambetov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

A. N. Noskov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

Yu. O. Selyaninov

National Research Institute for Veterinary Virology and Microbiology of Russia

Email: dim284@inbox.ru
Россия

I. L. Tutykhina

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

M. M. Shmarov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

D. Yu. Logunov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

B. S. Naroditskiy

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

A. L. Gintsburg

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Россия

References

  1. Guichard A., Nizet V., Bier E. // Microbes Infect. 2012. V. 14. № 2. P. 97-118.
  2. Brachman P.S. // Ann. N.Y. Acad. Sci. 1980. № 353. P. 83-93.
  3. Davies J.C.A. // Central African J. Med. 1982. № 28. P. 291-298.
  4. Davies J.C.A. // Central African J. Med. 1983. № 29. P. 8-12.
  5. Davies J.C.A. // Central African J. Med. 1985. № 31. P. 176-180.
  6. Metcalfe N. // Occup. Med. 2004. V. 54. № 7. P. 489-493.
  7. Meaney-Delman D., Zotti M.E., Rasmussen S.A., Strasser S., Shadomy S., Turcios-Ruiz R.M., Wendel G.D., Treadwell T.A., Jamieson D.J., Gladus M.A., et al. // Obstet. Gynecol. Dec. 2012. V. 120. № 6. P. 1439-1449.
  8. Ipatenko N.G., Gavrilov V.A., Manichev A.A., Bastarov S.I., Salenko L.S., Yakovleva T.N., Stepanova V.V., Shmorgun B.I., Kiselev Yu.T., Sayitkhulov B.S. // Veterinary. 1995. № 5. С. 27-30.
  9. Auerbach S., Wright G.G. // J. Immunol. 1955. V. 75. № 2. P. 129-133.
  10. Broster M.G., Hibbs S.E. // Salisbury Med. Bull. Sp. Suppl. 1990. № 68. P. 91-92.
  11. Little S.F., Knudson G.B., Neidhardt F.C. // Ann. Meet. Amer. Soc. Microbiol. 1984. P. 46.
  12. Ward M.K., McGann V.G., Hogge A.L., Huff M.L., Kanode R.G., Roberts E.O. // J. Infect. Dis. 1965. № 115. P. 59-67.
  13. McConnell M.J., Hanna P.C., Imperiale M.J. // Infect. Immun. 2006. V. 74. № 2. P. 1009-1015.
  14. Tan Y., Hackett N.R., Boyer J.L., Crystal R.G. // Hum. Gene. Ther. 2003. V. 14. № 17. P. 1673-1682.
  15. Hashimoto M., Boyer J.L., Hackett N.R., Wilson J.M., Crystal R.G. // Infect. Immun. 2005. V. 73. № 10. P. 6885-6891.
  16. Yu Y.Z., Li N., Wang W.B., Wang S., Ma Y., Yu W.Y., Sun Z.W. // Vaccine. 2010. V. 28. № 47. P. 7529-7535.
  17. McConnell M.J., Hanna P.C., Imperiale M.J. // Mol. Ther. 2007. V. 15. № 1. P. 203-210.
  18. Shcherbinin D. N., Shmarov M.M., Naroditsky B.S., Rubakova E.I., Kondrateva T.K. // Tubercullosis and lung diseases. 2010. V. 87. № 10. P. 50-53.
  19. Shcherbinin D. N., Tutyhina I.L., Logunov D.U.,Shmarov M.M., Apt A.S., Kondrateva T.K. Naroditsky B.S. //Med. immunol. 2010. V. 13. № 4-5. P. 347.
  20. Sigalov A.B. // Adv. Exp. Med. Biol. 2008. № 640. P. 121-163.
  21. Graham D.B., Akilesh H.M., Gmyrek G.B., Piccio L., Gilfillan S., Sim J., Belizaire R., Carrero J.A., Wang Y., Blaufuss G.S., et al. // Blood. 2010. V. 116. № 17. P. 3208-3218.
  22. Walport M.J. // N. Engl. J. Med. 2001. V. 344. № 14. P. 1058-1066.
  23. Tutykhina I.L., Logunov D.Y., Shcherbinin D.N., Shmarov M.M., Tukhvatulin A.I., Naroditsky B.S., Gintsburg A.L. // J. Mol. Med. 2011. V. 89. № 4. P. 331-341.
  24. Zhang J., Jex E., Feng T., Sivko G.S., Baillie L.W., Goldman S., van Kampen K.R., Tang D.C. // Clin. Vaccine Immunol. 2013. V. 20. № 1. P. 1-8.
  25. Radjainia M., Hyun J.K., Leysath C.E., Leppla S.H., Mitra A.K. // Proc. Natl. Acad. Sci. USA. 2010. V. 107. № 32. P. 14070-14074.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Shcherbinin D.N., Esmagambetov I.B., Noskov A.N., Selyaninov Y.O., Tutykhina I.L., Shmarov M.M., Logunov D.Y., Naroditskiy B.S., Gintsburg A.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies